164 results
Page 4 of 9
6-K
EX-99.2
gl2jmeyj8 rlfb2q0h5
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
jter2vsbjp8hw0pldbx
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
es5wv dfy
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
9l6of9v8ebam4j
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
z09ls7nci94 nh8
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.1
uhogg d6fk0i
30 Nov 20
RepliCel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis
10:05am
6-K
EX-99.1
rfh6jln
12 Nov 20
RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership
10:06am
6-K
EX-99.2
lgiow dwgjx58aogei
12 Nov 20
RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership
10:06am
6-K
EX-99.2
8kmz6la 0otnw8xqo
15 Oct 20
Condensed Consolidated Interim Financial Statements
5:15pm
6-K
EX-99.2
wvnjapu
8 Sep 20
Replicel Announces Extension to Private Placement
7:14pm
6-K
EX-99.3
yvuupk0
8 Sep 20
Replicel Announces Extension to Private Placement
7:14pm
6-K
EX-99.1
s37i4066x8g w7ze
8 Sep 20
Replicel Announces Extension to Private Placement
7:14pm
6-K
EX-99.4
jjjs r38m06z
8 Sep 20
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
1:17pm
6-K
EX-99.2
x1dvlc663fjxfag3vr6
8 Sep 20
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
1:17pm
6-K
EX-99.3
k8zrxg85 vx
8 Sep 20
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
1:17pm
6-K
EX-99.2
yo7fe ndoz32g7jdg
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.2
bka 4untog5a
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.1
qvzf7
23 Dec 19
RepliCel Announces its Incoming Board of Directors
5:21pm